Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore - PubMed (original) (raw)
. 1999 Apr 22;18(16):2537-46.
doi: 10.1038/sj.onc.1202625.
I Marzo, P Costantini, S A Susin, N Zamzami, P X Petit, F Hirsch, M Goulbern, M F Poupon, L Miccoli, Z Xie, J C Reed, G Kroemer
Affiliations
- PMID: 10353597
- DOI: 10.1038/sj.onc.1202625
Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore
L Ravagnan et al. Oncogene. 1999.
Abstract
The molecular mode of action of lonidamine, a therapeutic agent employed in cancer chemotherapy, has been elusive. Here we provide evidence that lonidamine (LND) acts on mitochondria to induce apoptosis. LND provokes a disruption of the mitochondrial transmembrane potential which precedes signs of nuclear apoptosis and cytolysis. The mitochondrial and cytocidal effects of LND are not prevented by inhibitors of caspases or of mRNA or protein synthesis. However, they are prevented by transfection-enforced overexpression of Bcl-2, an oncoprotein which inhibits apoptosis by stabilizing the mitochondrial membrane barrier function. Accordingly, the cell death-inducing effect of LND is amplified by simultaneous addition of PK11195, an isoquinoline ligand of the peripheral benzodiazepine receptor which antagonizes the cytoprotective effect of Bcl-2. When added to isolated nuclei, LND fails to provoke DNA degradation unless mitochondria are added simultaneously. In isolated mitochondria, LND causes the dissipation of the mitochondrial inner transmembrane potential and the release of apoptogenic factors capable of inducing nuclear apoptosis in vitro. Thus the mitochondrion is the subcellular target of LND. All effects of LND on isolated mitochondria are counteracted by cyclosporin A, an inhibitor of the mitochondrial PT pore. We therefore tested the effect of LND on the purified PT pore reconstituted into liposomes. LND permeabilizes liposomal membranes containing the PT pore. This effect is prevented by addition of recombinant Bcl-2 protein but not by a mutant Bcl-2 protein that has lost its apoptosis-inhibitory function. Altogether these data indicate that LND represents a novel type of anti-cancer agent which induces apoptosis via a direct effect on the mitochondrial PT pore.
Similar articles
- PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection.
Hirsch T, Decaudin D, Susin SA, Marchetti P, Larochette N, Resche-Rigon M, Kroemer G. Hirsch T, et al. Exp Cell Res. 1998 Jun 15;241(2):426-34. doi: 10.1006/excr.1998.4084. Exp Cell Res. 1998. PMID: 9637784 - Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore.
Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed J, Kroemer G. Larochette N, et al. Exp Cell Res. 1999 Jun 15;249(2):413-21. doi: 10.1006/excr.1999.4519. Exp Cell Res. 1999. PMID: 10366441 - The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition.
Zamzami N, Marzo I, Susin SA, Brenner C, Larochette N, Marchetti P, Reed J, Kofler R, Kroemer G. Zamzami N, et al. Oncogene. 1998 Feb 26;16(8):1055-63. doi: 10.1038/sj.onc.1201864. Oncogene. 1998. PMID: 9519879 - Mitochondrial control of apoptosis: an overview.
Kroemer G. Kroemer G. Biochem Soc Symp. 1999;66:1-15. doi: 10.1042/bss0660001. Biochem Soc Symp. 1999. PMID: 10989652 Review. - The central role of the mitochondrial megachannel in apoptosis: evidence obtained with intact cells, isolated mitochondria, and purified protein complexes.
Marzo I, Brenner C, Kroemer G. Marzo I, et al. Biomed Pharmacother. 1998;52(6):248-51. doi: 10.1016/S0753-3322(98)80009-7. Biomed Pharmacother. 1998. PMID: 9755823 Review.
Cited by
- Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
Milane L, Ganesh S, Shah S, Duan ZF, Amiji M. Milane L, et al. J Control Release. 2011 Oct 30;155(2):237-47. doi: 10.1016/j.jconrel.2011.03.032. Epub 2011 Apr 8. J Control Release. 2011. PMID: 21497176 Free PMC article. Review. - Mitochondrial metabolism inhibitors for cancer therapy.
Ramsay EE, Hogg PJ, Dilda PJ. Ramsay EE, et al. Pharm Res. 2011 Nov;28(11):2731-44. doi: 10.1007/s11095-011-0584-5. Epub 2011 Sep 15. Pharm Res. 2011. PMID: 21918915 Review. - Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting.
Cuchelkar V, Kopecková P, Kopecek J. Cuchelkar V, et al. Mol Pharm. 2008 Sep-Oct;5(5):776-86. doi: 10.1021/mp800019g. Epub 2008 Sep 4. Mol Pharm. 2008. PMID: 18767867 Free PMC article. - Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle.
Skalska J, Debska G, Kunz WS, Szewczyk A. Skalska J, et al. Br J Pharmacol. 2005 Jul;145(6):785-91. doi: 10.1038/sj.bjp.0706214. Br J Pharmacol. 2005. PMID: 15895111 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources